Biostage, Inc. carries a market capitalization of 57.82M, placing it among publicly traded companies globally.
| Market Cap | 57.82M |
| Enterprise Value | N/A |
Biostage, Inc.'s stock has declined approximately -11.42857% over the past 52 weeks. The 50-day moving average sits at 4.75, while the 200-day moving average is 5.89.
| Beta (5Y) | N/A |
| 52-Week Price Change | -11.42857% |
| 50-Day Moving Average | 4.75 |
| 200-Day Moving Average | 5.89 |
| Average Volume (20 Days) | N/A |
Biostage, Inc.'s most recent stock split took place on December 22, 2017 with a 20:1 split ratio.
| Last Split Date | 12/22/2017 |
| Split Ratio | 20:1 |